Literature DB >> 11504086

Regional alterations of myocardial norepinephrine transporter density in streptozotocin-induced diabetic rats: implications for heterogeneous cardiac accumulation of MIBG in diabetes.

Y Kiyono1, Y Iida, H Kawashima, N Tamaki, H Nishimura, H Saji.   

Abstract

Cardiac scintigraphic studies using iodine-123 labeled metaiodobenzylguanidine ([123I]MIBG) have previously demonstrated the heterogeneous myocardial accumulation of radioactivity in diabetes. In this study, we investigated the myocardial regional distribution of [125I]MIBG and the effects of regional myocardial blood flow, myocardial norepinephrine (NE) content, and norepinephrine transporter (NET) function on regional [125I]MIBG accumulation in streptozotocin-induced diabetic (STZ-D) rats. Dual-isotope autoradiographic studies using [125I]MIBG and technetium-99m labeled hexakis (2-methoxy-2-isobutylisonitrile) (99mTc-MIBI), a tracer for the measurement of myocardial blood flow, were carried out to investigate the changes in regional myocardial blood flow in STZ-D rats. Uptake of [125I]MIBG was similar between the anterior wall and the inferior wall in control rats. On the other hand, in STZ-D rats, uptake of [125I]MIBG in the inferior wall was significantly less than that in the anterior wall. Uptake of 99mTc-MIBI was not significantly different between the anterior and inferior walls in control or STZ-D rats, indicating that myocardial blood flow did not change regionally in either control or STZ-D rats, and that the blood flow was not responsible for the heterogeneity of the distribution of [125I]MIBG in STZ-D rats. In STZ-D rats, cardiac NE concentrations determined using an HPLC-electrochemical detection (ECD) system were significantly increased in both the anterior and the inferior wall, although there was no significant difference in NE concentration between the anterior and inferior walls in control or STZ-D rats. Furthermore, the density and affinity of NET were investigated by studying the binding of [3H]desipramine to cardiac membranes. The Bmax values of the NET in the anterior wall were not significantly different between control and STZ-D rats, but the Bmax value of the NET in the inferior wall was significantly lower in STZ-D rats than in controls. In conclusion, myocardial MIBG uptake was reduced in the inferior wall of STZ-D rats compared with control rats; this decrease was correlated with the decrease in NET density, but was not dependent on the regional myocardial blood flow and NE concentration. These results suggest that regional fluctuations in NET levels in the inferior wall contribute to heterogeneous MIBG accumulation in diabetes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11504086     DOI: 10.1007/s002590100550

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  9 in total

Review 1.  Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease.

Authors:  Valerie Joers; Marina E Emborg
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-03-20

2.  How do we establish cardiac sympathetic nervous system imaging with 123I-mIBG in clinical practice? Perspectives and lessons from Japan and the US.

Authors:  Mark I Travin; Ichiro Matsunari; Gregory S Thomas; Kenichi Nakajima; Keiichiro Yoshinaga
Journal:  J Nucl Cardiol       Date:  2018-09-03       Impact factor: 5.952

3.  Influence of the polyol pathway on norepinephrine transporter reduction in diabetic cardiac sympathetic nerves: implications for heterogeneous accumulation of MIBG.

Authors:  Yasushi Kiyono; Satomi Kajiyama; Hiromi Fujiwara; Naoki Kanegawa; Hideo Saji
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-11-26       Impact factor: 9.236

4.  Influence of the polyol pathway on norepinephrine transporter reduction in diabetic cardiac sympathetic nerves: implications for heterogeneous accumulation of MIBG.

Authors:  Yasushi Kiyono; Satomi Kajiyama; Hiromi Fujiwara; Naoki Kanegawa; Hideo Saji
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-08       Impact factor: 9.236

5.  Early diabetes treatment does not prevent sympathetic dysinnervation in the streptozotocin diabetic rat heart.

Authors:  James T Thackeray; Robert A deKemp; Rob S Beanlands; Jean N DaSilva
Journal:  J Nucl Cardiol       Date:  2014-06-03       Impact factor: 5.952

6.  Insulin restores myocardial presynaptic sympathetic neuronal integrity in insulin-resistant diabetic rats.

Authors:  James T Thackeray; Robert A deKemp; Rob S Beanlands; Jean N DaSilva
Journal:  J Nucl Cardiol       Date:  2013-07-11       Impact factor: 5.952

7.  Altered sympathetic nervous system signaling in the diabetic heart: emerging targets for molecular imaging.

Authors:  James T Thackeray; Rob S Beanlands; Jean N Dasilva
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-07-20

8.  Sympathetic nervous dysregulation in the absence of systolic left ventricular dysfunction in a rat model of insulin resistance with hyperglycemia.

Authors:  James T Thackeray; Jerry Radziuk; Mary-Ellen Harper; Erik J Suuronen; Kathryn J Ascah; Rob S Beanlands; Jean N Dasilva
Journal:  Cardiovasc Diabetol       Date:  2011-08-10       Impact factor: 9.951

9.  Dynamic monitoring of single-terminal norepinephrine transporter rate in the rodent cardiovascular system: A novel fluorescence imaging method.

Authors:  Lily L Cao; Andrew P Holmes; Janice M Marshall; Larissa Fabritz; Keith L Brain
Journal:  Auton Neurosci       Date:  2019-12-26       Impact factor: 3.145

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.